I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

*Helicobacter pylori* (HP) is a gram-negative bacterium, and it mainly colonizes in the mucosa. With the expression of two genes named *VacA* and *CagA*, HP is divided into two main types: type I contains both genes, and type II only contains *VacA*.\[[@ref1]\]

At present, the rate of HP infection exceeds 50% worldwide and 80% in Africa.\[[@ref2]\] Innate immunity and adaptive immunity are activated after HP infection, and multiple organs are affected.\[[@ref3]\] The research on HP infection has put most of the attention on gastrointestinal diseases, such as chronic gastritis and peptic ulcers, in the past years.\[[@ref4][@ref5]\] However, in recent years, the association between HP infection and extragastric diseases has garnered more attention in recent years, as shown in [Figure 1](#F1){ref-type="fig"}.

![The association between HP infection and extragastric diseases. The association between HP infection and extragastric diseases has garnered more attention in recent years, as related to cognitive impairment, CHD, COPD, CB, metabolic syndrome and renal disease. HP: *Helicobacter pylori*; CHD: Coronary heart disease; COPD: Chronic obstructive pulmonary disease; CB: Chronic bronchitis.](CMJ-131-2734-g001){#F1}

For example, the association between neurological disease and HP infection has been of interest. In 2015, it was reported by Wright *et al*.\[[@ref6]\] that the risk of vascular cognitive impairment increased in patients exposed to HP. In addition, Sun *et al*.\[[@ref7]\] conducted a meta-analysis of the association between HP infection and the risk of coronary heart disease (CHD) in 2016, showing that HP infection increased the risk of CHD by 11% (risk ratio: 1.11; confidence interval \[*CI*\] 1.01--1.22), especially in the early life of patients.

The incidence of HP infection was higher in patients with chronic obstructive pulmonary disease and chronic bronchitis than that in controls (odds ratio \[*OR*\] 2.07, 95% *CI* 1.81--2.36, *P* for heterogeneity = 0.05; and *OR* 1.57, 95% *CI*: 1.33--1.86, *P* for heterogeneity = 0.08).\[[@ref8]\] In 2016, it was reported that the prevalence of type 2 diabetes (T2DM) was significantly higher in patients with HP infection than in HP-negative patients (21.3% vs. 20.2%, *P* = 0.026).\[[@ref9]\] A significant association between serum HP IgG antibody and renal function was also reported in 2013.\[[@ref10]\] The association between HP infection and extragastric diseases was shown in [Figure 1](#F1){ref-type="fig"}.

In 2013, there were 382 million people with diabetes in the world, and this number is expected to reach 592 million by 2035.\[[@ref11]\] Diabetic nephropathy is a serious complication of diabetes, and it is the leading cause of end-stage renal disease in developed countries.\[[@ref12]\] The mechanism of T2DM nephropathy is multifactorial.\[[@ref13][@ref14]\] Proteinuria is a significant marker in the early diagnosis of T2DM nephropathy and can be used as a sensitive indicator of renal function in patients with T2DM nephropathy,\[[@ref15]\] having a certain reference value for the clinical treatment of T2DM patients.

In T2DM patients, proteinuria not only marks the glomerular filtration barrier injury but also implicates vascular endothelial dysfunction.\[[@ref16]\] Various complications of diabetes are associated with the occurrence of proteinuria, such as hypertension, hypercholesterolemia, diabetic retinopathy, atherosclerosis, and cardiovascular complications.\[[@ref17][@ref18][@ref19]\]

Within a large diabetic population, the prognosis of patients with proteinuria is serious, and there is a certain coping strategy for HP infection.\[[@ref20][@ref21]\] An increasing amount of research focuses on the interaction between HP infection and renal function. However, controversy still exists about the association between HP infection and the occurrence of proteinuria in T2DM patients. This controversy may be due to the small sample size, diversity of research methods, and differences in the epidemiological distribution of HP. To overcome these difficulties, we conducted a meta-analysis to further explore the association between HP infection and the occurrence of proteinuria in T2DM patients.

M[ETHODS]{.smallcaps} {#sec1-2}
=====================

Search strategies {#sec2-1}
-----------------

This study was conducted with the Cochrane Collaboration methodology.\[[@ref22]\] The reporting utilized the meta-analysis of observational studies in epidemiology group methodology.\[[@ref23]\]

Search strategies were formulated by relevant professionals. The search strategies included "diabetic proteinuria, diabetic microalbuminuria, diabetic albuminuria, diabetic kidney disease, diabetic renal dysfunction, diabetic renal disease, diabetic nephropathy, diabetic complications, and diabetic mellitus, combined with HP." Relevant English or Chinese studies were searched on online databases before 2018, including PubMed, the Cochrane library, Medline, Google Scholar, the China National Infrastructure, and Wanfang database.

Articles selection {#sec2-2}
------------------

We screened a total of 655 related articles. After removing articles after identifying duplicate and apparently nonconforming articles, eleven articles involved in this meta-analysis met the inclusion and exclusion criteria; however, after reading the abstract and full text, four of these articles did not provide the relevant data, and we were unable to obtain the data after contacting the corresponding authors. Thus, seven articles were ultimately included.\[[@ref24][@ref25][@ref26][@ref27][@ref28][@ref29][@ref30]\] The process of articles selection is shown in [Figure 2](#F2){ref-type="fig"}.

![The process of article selection. We screened a total of 655 related articles, with 47 articles excluded because of repetition. After utilizing the inclusion and exclusion criteria for the abstract and full text of the remaining articles, seven were finally included in our meta-analysis.](CMJ-131-2734-g002){#F2}

Inclusion criteria {#sec2-3}
------------------

Inclusion criteria included: (1) the study type was case-control, (2) Chinese or English articles, (3) participants with T2DM, (4) participants with HP infection, and (5) participants with the diagnostic criteria for proteinuria.

Exclusion criteria {#sec2-4}
------------------

Exclusion criteria included: (1) articles' full texts were unobtainable, (2) proteinuria diagnosis was not clear, (3) numbers of T2DM patients with and without HP infection were not provided, and (4) animal studies.

Definitions of proteinuria and *Helicobacter pylori* infection {#sec2-5}
--------------------------------------------------------------

The urinary albumin excretion of more than 30 mg/24 h or a urinary albumin to creatinine ratio of \>30 mg/g was considered proteinuria. HP infection was diagnosed by serum HP IgG antibodies, a 14C-urea breath test, a rapid urease test and gastroduodenoscopy mucosal biopsies.

Data extraction {#sec2-6}
---------------

The quality of the seven included articles was separately assessed by two investigators using the Newcastle--Ottawa Scale (NOS).\[[@ref31]\] A third person was involved in the discussions and decisions regarding the articles that had different scores. The qualities of these seven articles were all above five stars as assessed by NOS. The four-fold table was then drafted, and the data from each article were extracted by two investigators. The basic information of each article, such as the first author\'s name, country of origin, sample size, and published time of each article, was also extracted by two investigators, as shown in [Table 1](#T1){ref-type="table"}.

###### 

Basic characteristics of the included seven articles

  Studies                         Year   Country       Study design         Case/control (*n*)   Ethnicity (mean age of case group and control group, years)                                               NOS quality assessment
  ------------------------------- ------ ------------- -------------------- -------------------- --------------------------------------------------------------------------------------------------------- ------------------------
  Gulcelik *et al*.\[[@ref24]\]   2005   Turkey        Case-control study   31/71                The population of Ankara Training Hospital (51.9 ± 10.6, 48.2 ± 8.3)                                      ★★★★★
  Kayar *et al*.\[[@ref25]\]      2014   Turkey        Case-control study   23/39                The population of internal medicine outpatient clinic. (48.6 ± 12.1, 47.3 ± 12.6)                         ★★★★★★
  Ohnishi *et al*.\[[@ref26]\]    2008   Japan         Case-control study   61/69                The population of Matsushita Memoril Hospital (64.2 ± 11.6, 71.3 ± 14.4)                                  ★★★★★
  Zhou *et al*.\[[@ref27]\]       2015   China         Case-control study   125/65               The population of the hospital in Qingdao. (50.2 ± 12.6, 45.6 ± 12.1)                                     ★★★★★★
  Demir *et al*.\[[@ref28]\]      2008   Turkey        Case-control study   21/120               The population of Baskent University Konya Hospital. (52.8 ± 10.1, 52.6 ± 10.2)                           ★★★★★
  Chung *et al*.\[[@ref29]\]      2013   South Korea   Case-control study   68/256               The population of Seoul National University Healthcare System Gangnam Center. (57.7 ± 10.5, 54.6 ± 9.1)   ★★★★★
  Hamed *et al*.\[[@ref30]\]      2007   Egypt         Case-control study   37/43                The population of Assiut University Hospital. (47.7 ± 9.2, 47.7 ± 9.1)                                    ★★★★★

Data analysis {#sec2-7}
-------------

Data analysis used RevMan 5.3 software (The Cochrane Collaboration, Copenhagen, Denmark) as recommended by the Cochrane Library. I-square (*I*^2^) test was used to assess the heterogeneity of the studies involved in our meta-analysis.\[[@ref32]\] When severe heterogeneity, which was defined as *I*^2^ ≥50%, was found, a random-effects model was used; otherwise, a fixed-effects model was used according to the Cochrane review guidelines. *I*^2^ = 46% in this study; thus, a fixed-effects model was adopted.

The *OR* with 95% *CI* was used to evaluate the association between HP infection and the occurrence of proteinuria in T2DM patients. A statistically significant association was defined as *P* \< 0.05. Publication bias was evaluated by funnel plots. Omitting one study in each turn was used to estimate the sensitivity of our meta-analysis.

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

Basic characteristics of included articles {#sec2-8}
------------------------------------------

There were seven case--control studies involved in our study, those were in accordance with the inclusion and exclusion criteria. A total of 1029 participants were involved in our meta-analysis, including 366 patients in the case group and 663 in the control group. The basic characteristics and the detailed NOS score of these included seven articles are shown in [Table 1](#T1){ref-type="table"} and [Supplementary Table 1](#T2){ref-type="table"}, respectively.

###### 

NOS score of the included articles

  Author                Is the case definition adequate                                                  Representativeness of the cases                            Selection of controls                                     Definition of controls              
  --------------------- -------------------------------------------------------------------------------- ---------------------------------------------------------- --------------------------------------------------------- ----------------------------------- ----------------------------
  N.E,.Gulcelik         Yes, with independent validation★                                                Consecutive or obviously representative series of cases★   No description                                            No history of disease (endpoint)★   
  Goh Eun Chung         Yes, with independent validation★                                                Potential for selection biases or not stated               Hospital controls                                         No history of disease (endpoint)★   
  Masayoshi Ohnishi     Yes, with independent validation★                                                Potential for selection biases or not stated               Hospital controls                                         No history of disease (endpoint)★   
  Fei Zhou              Yes, with independent validation★                                                Consecutive or obviously representative series of cases★   No description                                            No history of disease (endpoint)★   
  Mehmet Demir          Yes, with independent validation★                                                Potential for selection biases or not stated               Hospital controls                                         No history of disease (endpoint)★   
  Yusuf Kayar           Yes, with independent validation★                                                Consecutive or obviously representative series of cases★   No description                                            No history of disease (endpoint)★   
  Sherifa Ahmed Hamed   Yes, with independent validation★                                                Potential for selection biases or not stated               No description                                            No history of disease (endpoint)★   
                                                                                                                                                                                                                                                                  
  **Author**            **Comparability of cases and controls on the basis of the design or analysis**   **Ascertainment of exposure**                              **Same method of ascertainment for cases and controls**   **Nonresponse rate**                **NOS quality assessment**
                                                                                                                                                                                                                                                                  
  N.E,.Gulcelik         Select the most important factor★                                                Secure record (e.g., surgical records)★                    Yes★                                                      Nonrespondents described            ★★★★★★
  Goh Eun Chung         Select the most important factor★                                                Secure record (e.g., surgical records)★                    Yes★                                                      Nonrespondents described            ★★★★★
  Masayoshi Ohnishi     Select the most important factor★                                                Secure record (e.g., surgical records)★                    Yes★                                                      Nonrespondents described            ★★★★★
  Fei Zhou              Select the most important factor★                                                Secure record (e.g., surgical records)★                    Yes★                                                      Nonrespondents described            ★★★★★★
  Mehmet Demir          Select the most important factor★                                                Secure record (e.g., surgical records)★                    Yes★                                                      Nonrespondents described            ★★★★★
  Yusuf Kayar           Select the most important factor★                                                Secure record (e.g., surgical records)★                    Yes★                                                      Nonrespondents described            ★★★★★★
  Sherifa Ahmed Hamed   Select the most important factor★                                                Secure record (e.g., surgical records)★                    Yes★                                                      Nonrespondents described            ★★★★★

NOS: Newcastle--Ottawa Scale.

Results of meta-analysis {#sec2-9}
------------------------

There was a significant correlation between HP infection and the occurrence of proteinuria in T2DM patients. The rate of HP infection in T2DM patients with proteinuria was significantly higher than the rate without HP infection (*OR* = 2.00, 95% *CI*: 1.48--2.69), as shown in [Figure 3](#F3){ref-type="fig"}.

![Forest plot. The rate of HP infection in T2DM patients with proteinuria was significantly higher than that in patients without HP infection (*OR* = 2.00, 95% *CI* \[1.48, 2.69\]). HP: *Helicobacter pylori*; T2DM: Type 2 diabetes; *OR*: Odds ratio; *CI*: Confidence interval.](CMJ-131-2734-g003){#F3}

Assessment of publication bias {#sec2-10}
------------------------------

The publication bias of the involved studies was assessed by a funnel plot conducted by the use of RevMan. Each point in the funnel plot represents an article. The distribution of these points was roughly symmetrical on the funnel plot, as shown in [Figure 4](#F4){ref-type="fig"}, meaning that there was no significant publication bias in our meta-analysis.

![Funnel plot. The distribution of these articles is roughly symmetrical on the funnel plot, meaning that there was no significant publication bias in our meta-analysis.](CMJ-131-2734-g004){#F4}

D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

After our meta-analysis, we found that HP infection was significantly associated with the occurrence of proteinuria in T2DM patients. This result suggested that HP infection played an important role in the process of renal dysfunction in T2DM patients. However, to the best of our knowledge, studies on the mechanism of this role currently remain scarce. The main focus of current articles is as follows.

First, people with diabetes are susceptible to HP. It has been reported that the rate of HP infection is as high as 75.6% in diabetes patients.\[[@ref24]\] Moreover, the longer the diabetes duration is, the higher the rate of HP infection.\[[@ref33]\] The mechanism of the high incidence of HP in T2DM patients is very complex; there are many factors involved in this process, and it is believed that cellular and humoral disorders are the main causes. The gastric mucosal surface is altered in T2DM patients.\[[@ref31]\] The HP infection will be initiated by the overgrowth of upper gastrointestinal bacteria that is caused by delayed gastric emptying and dysfunction of glucose regulation in the T2DM patient.\[[@ref34]\] It is speculated that the mechanism may be related to insulin resistance caused by HP infection in T2DM patients.\[[@ref35][@ref36]\]

HP infection often occurs in early childhood and will last a patient\'s whole life, whereas only a small percentage of HP-infected patients have obvious symptoms.\[[@ref37]\] A complex balance between the human immune system and the HP after HP infection develops, resulting in a long state of chronic infection.\[[@ref3][@ref38]\]

The innate and adaptive immune system can be activated after HP infection, and there is a significant increase in interleukin-6 (IL-6), IL-8, IL-10, and tumor necrosis factor α (TNF-α).\[[@ref3]\] A large number of immune complexes will subsequently be formed in a long-term inflammation.\[[@ref39]\] Many organs and tissues can be affected, especially the kidney, which can be damaged by inflammatory cytokines, inflammatory cells, and immune complexes in T2DM patients.\[[@ref40]\]

TNF-α is considered the main factor that is responsible for the increase in urinary albumin in T2DM patients.\[[@ref41]\] The glomerular epithelial cells are directly damaged by the elevation of TNF-α. TNF-α can also promote the damage of the renal interstitium through the formation of peroxide.\[[@ref42]\] After HP infection, IL-6 can promote glomerular sclerosis by increased production of the extracellular matrix and mesangial proliferation.\[[@ref43]\]

In addition, it has been reported that, after HP infection, cross-reactivity appears between the host antigens and the inflammatory factors that are generated.\[[@ref44]\] The permeability of glomerular basement membrane can also be changed by an increase in TNF-α and IL-1 after HP infection, leading to proteinuria.\[[@ref45]\] In addition, granular deposits have been found in glomerular capillaries in patients with membranous nephropathy (MN), and these granular deposits were positive for HP-specific antibodies.\[[@ref46]\] Although there are few relevant reports on T2DM patients, we speculated that immunoprecipitation can be caused by a reaction between HP antibodies and podocyte antigens in the glomerulus.

The mechanism of the increased urinary protein excretion in T2DM patients is complex, but endothelial cell dysfunction is one of the major reasons.\[[@ref47]\] Some studies have shown that HP infection is associated with endothelial dysfunction and injury of the vascular system.\[[@ref48][@ref49]\] Cellular and humoral immunity is impaired in patients with T2DM; thus, bacteria invade the vascular wall more often in T2DM patients than that in patients without T2DM. If the level of B12 and folic acid is decreased after HP infection, the T2DM patients are then susceptible to atrophic gastritis; furthermore, the level of homocysteine will then be increased after HP infection in T2DM patients, risking injury of the vascular system.\[[@ref45]\]

As far as we know, there is a close correlation between proteinuria and markers of endothelial cell dysfunction, such as von Willebrand factor, endothelin, tissue plasminogen activator, and fibrinogen, in T2DM patients.\[[@ref50]\] Considering that the increase in inflammatory factors after HP infection in T2DM patients may be closely related to the dysfunction of endothelial and vascular injury, the promotion of the occurrence of proteinuria in T2DM patients with HP infection may occur.

In 2016, it was reported that early HP eradication is beneficial to patients with HP infection to avoid the occurrence of chronic kidney diseases.\[[@ref51]\] Since proteinuria in patients with MN is decreased after HP eradication,\[[@ref52]\] we speculated that HP eradication may be useful for T2DM patients in an effort to reduce the risk of proteinuria.

In summary, T2DM patients are susceptible to HP infection. The dysfunction of vascular endothelial cells and chronic inflammation after HP infection may be the main reasons for the occurrence of proteinuria in T2DM patients. Thus, there may be a breakthrough of the protection of renal function in T2DM patients if we place more focus on the research of inflammation markers and vascular injury after HP infection.

HP eradication therapies could be recommended to reduce the risk of proteinuria in diabetes patients with HP infection, especially for those patients with a higher risk of diabetic complications.

*Supplementary information is linked to the online version of the paper on the Chinese Medical Journal website*.
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